NURS6670 Walde Safe Prescribing for Psychiatric Mental Health NP Paper Safe Prescribing There is probably no greater responsibility that the psychiatric me

NURS6670 Walde Safe Prescribing for Psychiatric Mental Health NP Paper Safe Prescribing There is probably no greater responsibility that the psychiatric mental health nurse practitioner assumes than the responsibility of prescribing medications. While someone can be harmed by psychotherapy, the level and intensity of the harm generally does not come to the same level of harm that can occur from improper prescribing. The PMHNP must understand his/her responsibility both at a state and federal level when it comes to prescribing medications. In this Assignment, you will explore the legalities associated with prescribing controlled substances, as well as what a DEA number is, how to obtain one, and, most importantly, how to prescribe controlled substances in your state (Texas). Learning Objectives: Students will: Analyze roles of the Drug Enforcement Administration Analyze PMHNP responsibilities when issued a DEA number Analyze DEA number application procedures Analyze state requirements for safe prescribing and prescription monitoring Analyze PMHNP responsibilities for safe prescribing and prescription monitoring Analyze Schedule II-V drug levels To prepare for this: Review the Learning Resources. The Actual Assignment: Write a 3 page paper in which you do the following: Describe the role of the Drug Enforcement Administration (DEA) as it pertains to the PMHNP. Explain your responsibilities when having a DEA number. Explain how you apply for a DEA number. Explain Texas state’s requirements for a safe prescribing and prescription monitoring program. Explain your responsibility as a PMHNP to follow these requirements. Provide an example of a drug you may prescribe from each of the Schedule II-V drug levels. REFERENCES (Any additional references should be from 2015 to present) Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer. Stahl, S. M. (2014). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (5th ed.). New York, NY: Cambridge University Press. Drug Enforcement Administration. (n.d.). Drug schedules. Retrieved June 14, 2016, from https://www.dea.gov/druginfo/ds Safe Prescribing
There is probably no greater responsibility that the psychiatric mental health nurse practitioner assumes
than the responsibility of prescribing medications. While someone can be harmed by psychotherapy, the
level and intensity of the harm generally does not come to the same level of harm that can occur from
improper prescribing. The PMHNP must understand his/her responsibility both at a state and federal
level when it comes to prescribing medications.
In this Assignment, you will explore the legalities associated with prescribing controlled substances, as
well as what a DEA number is, how to obtain one, and, most importantly, how to prescribe controlled
substances in your state (Texas).
Learning Objectives: Students will:
• Analyze roles of the Drug Enforcement Administration
• Analyze PMHNP responsibilities when issued a DEA number
• Analyze DEA number application procedures
• Analyze state requirements for safe prescribing and prescription monitoring
• Analyze PMHNP responsibilities for safe prescribing and prescription monitoring
• Analyze Schedule II-V drug levels
To prepare for this:
• Review the Learning Resources.
The Actual Assignment: Write a 3 page paper in which you do the following:
1.
Describe the role of the Drug Enforcement Administration (DEA) as it pertains to the PMHNP.
2.
Explain your responsibilities when having a DEA number.
3.
Explain how you apply for a DEA number.
4.
Explain Texas state’s requirements for a safe prescribing and prescription monitoring
program. Explain your responsibility as a PMHNP to follow these requirements.
5.
Provide an example of a drug you may prescribe from each of the Schedule II-V drug levels.
REFERENCES (Any additional references should be from 2015 to present)
Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral
sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer.
Stahl, S. M. (2014). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (5th ed.). New York, NY:
Cambridge University Press.
Drug Enforcement Administration. (n.d.). Drug schedules. Retrieved June 14, 2016, from
https://www.dea.gov/druginfo/ds

Purchase answer to see full
attachment